SOLID TUMOR, ADULT
Clinical trials for SOLID TUMOR, ADULT explained in plain language.
Never miss a new study
Get alerted when new SOLID TUMOR, ADULT trials appear
Sign up with your email to follow new studies for SOLID TUMOR, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer-Killing virus VAXINIA tested in patients with advanced tumors
Disease control TerminatedThis early-phase study tested a new treatment called VAXINIA (a virus designed to attack cancer cells) in 66 adults with advanced solid tumors that had spread. The virus was given alone or with an immunotherapy drug (pembrolizumab), either as a shot into the tumor or through an I…
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: Imugene Limited • Aim: Disease control
Last updated May 16, 2026 23:48 UTC
-
New cancer drug GEN2 tested in patients – study halted early
Disease control TerminatedThis early-phase study tested a new drug called GEN2 in 37 adults with advanced solid tumors that had stopped responding to other treatments. The goal was to find a safe dose and check for side effects. The study was terminated early, so results are limited.
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: GenVivo, Inc. • Aim: Disease control
Last updated May 16, 2026 23:48 UTC
-
New pill shows promise against Hard-to-Treat cancers
Disease control TerminatedThis early-phase study tested a new daily pill, NKT3447, in 23 adults with advanced solid tumors (like ovarian, endometrial, or lung cancer) that had stopped responding to standard treatments. The goal was to check safety and find the right dose. The study was stopped early, so r…
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 16, 2026 23:48 UTC
-
New cancer drug shows promise in early trial
Disease control TerminatedThis study tested a new drug called BGB-24714 in 157 people with advanced solid tumors that had spread or couldn't be removed. The goal was to find safe doses and see if the drug shrinks tumors when used alone or with chemotherapy or radiation. The trial was stopped early, but re…
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated May 16, 2026 23:47 UTC
-
Experimental virus combo targets Hard-to-Treat cancers
Disease control TerminatedThis early-phase study tested a new treatment called onCARlytics (CF33-CD19) given alone or with another drug (blinatumomab) in adults with advanced solid tumors that had not responded to prior therapies. The main goal was to check safety and find the best dose. The study was ter…
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: Imugene Limited • Aim: Disease control
Last updated May 16, 2026 23:47 UTC
-
Experimental cancer pill shows early promise but study halted
Disease control TerminatedThis early-phase study tested an experimental oral drug called IK-595 in 75 adults with advanced solid tumors (like colorectal, pancreatic, or lung cancer) that have specific RAS or RAF gene mutations. The goal was to check safety, find the right dose, and see if it shrinks tumor…
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: Ikena Oncology • Aim: Disease control
Last updated May 16, 2026 23:47 UTC
-
Early-Stage cancer drug trial halted after just 3 patients
Disease control TerminatedThis early-phase study tested a new drug called AXN-2510 in 3 adults with advanced solid tumors that had stopped responding to other treatments. The main goals were to find safe doses and understand side effects. The trial was terminated early, so results are limited.
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: Axion Bio, Inc • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New cancer pill tested, but study halted early
Disease control TerminatedThis early-stage study tested an experimental oral drug called AUR105 in 17 adults with advanced solid tumors or lymphomas that had come back. The main goals were to check safety, how the drug moves through the body, and find the right dose. The study was stopped early, so result…
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis early-stage study tested a new drug called AUR103 Calcium in 27 adults with advanced cancers that had stopped responding to standard treatments. The goal was to find a safe dose and see how the drug worked in the body. The trial was terminated early, so no final results are …
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated May 14, 2026 12:06 UTC